Skip to main content
. 2016 May 23;34(20):2333–2340. doi: 10.1200/JCO.2015.64.8899

Fig 2.

Fig 2.

Cumulative response rates over time. The percentages of patients with (A) major molecular response (MMR) and (B) molecular response with a 4.5-log reduction in BCR-ABL1 transcripts from baseline (MR4.5; BCR-ABL1 transcript level ≤ 0.0032% [International Scale]) by 1, 2, 3, 4, and 5 years are shown.